BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33391501)

  • 1. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis.
    Hu ZL; Luo C; Hurtado PR; Li H; Wang S; Hu B; Xu JM; Liu Y; Feng SQ; Hurtado-Perez E; Chen K; Zhou XF; Li CQ; Dai RP
    Theranostics; 2021; 11(2):715-730. PubMed ID: 33391501
    [No Abstract]   [Full Text] [Related]  

  • 2. proBDNF/p75NTR promotes rheumatoid arthritis and inflammatory response by activating proinflammatory cytokines.
    Yang CR; Ding HJ; Yu M; Zhou FH; Han CY; Liang R; Zhang XY; Zhang XL; Meng FJ; Wang S; Li DD; Sun WZ; Meng B; Zhou XF
    FASEB J; 2022 Mar; 36(3):e22180. PubMed ID: 35129860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
    Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
    Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Agrawal SM; Silva C; Tourtellotte WW; Yong VW
    J Neurosci; 2011 Jan; 31(2):669-77. PubMed ID: 21228176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
    Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
    Front Immunol; 2021; 12():792465. PubMed ID: 34975892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of proBDNF/p75NTR signaling in immune cells and its correlation with inflammatory markers in patients with major depression.
    Yang CR; Liang R; Liu Y; Meng FJ; Zhou F; Zhang XY; Ning L; Wang ZQ; Liu S; Zhou XF
    FASEB J; 2024 Jan; 38(1):e23312. PubMed ID: 38161282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ProBDNF promotes sepsis-associated encephalopathy in mice by dampening the immune activity of meningeal CD4
    Luo RY; Luo C; Zhong F; Shen WY; Li H; Hu ZL; Dai RP
    J Neuroinflammation; 2020 May; 17(1):169. PubMed ID: 32466783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of proBDNF in the Mesenteric Lymph Nodes in Septic Mice.
    Wang Z; Wu JL; Zhong F; Liu Y; Yu YQ; Sun JJ; Wang S; Li H; Zhou XF; Hu ZL; Dai RP
    Neurotox Res; 2019 Oct; 36(3):540-550. PubMed ID: 31278527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of B cell subsets in central pathological process of autoimmune encephalomyelitis in mice.
    Xiong Y; Cheng S; Wu X; Ren Y; Xie X
    BMC Immunol; 2019 Jul; 20(1):24. PubMed ID: 31286875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
    Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
    Front Immunol; 2019; 10():2437. PubMed ID: 31681317
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a CD19 PET tracer for detecting B cells in a mouse model of multiple sclerosis.
    Stevens MY; Cropper HC; Lucot KL; Chaney AM; Lechtenberg KJ; Jackson IM; Buckwalter MS; James ML
    J Neuroinflammation; 2020 Sep; 17(1):275. PubMed ID: 32948198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
    Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2019; 10():1921. PubMed ID: 31497013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.